Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02520011
Brief Title: Alvocidib Biomarker-driven Phase 2 AML Study

First Submitted : August 6, 2015
First Submitted that Met QC Criteria : August 6, 2015
First Posted : August 11, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : May 21, 2019
Last Update Posted : May 23, 2019